The key efficacy endpoint from the 4 years of procedures try day to first experience out-of AUR otherwise BPH-related procedures
The key efficacy endpoint from the 4 years of procedures try day to first experience out-of AUR otherwise BPH-related procedures After 4 years of treatment, combination therapy statistically significantly reduced the risk of AUR or BPH-related surgery (65.8% reduction in risk p<0.001 [95% CI 54.7% to 74.1%]) compared to tamsulosin monotherapy. 2% for combination therapy …